Sumati Gupta

3.5k total citations
110 papers, 1.3k citations indexed

About

Sumati Gupta is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sumati Gupta has authored 110 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Oncology, 46 papers in Surgery and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sumati Gupta's work include Bladder and Urothelial Cancer Treatments (45 papers), Cancer Immunotherapy and Biomarkers (26 papers) and Prostate Cancer Treatment and Research (22 papers). Sumati Gupta is often cited by papers focused on Bladder and Urothelial Cancer Treatments (45 papers), Cancer Immunotherapy and Biomarkers (26 papers) and Prostate Cancer Treatment and Research (22 papers). Sumati Gupta collaborates with scholars based in United States, Italy and United Kingdom. Sumati Gupta's co-authors include George A. Bonanno, Benjamin L. Maughan, Sumanta K. Pal, Paul Nathan, Petros Grivas, Fiona Thistlethwaite, Yoshihiko Tomita, Thomas Powles, James Larkin and Mototsugu Oya and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Sumati Gupta

98 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sumati Gupta United States	19	552	458	417	402	191	110	1.3k
Mitchell I. Edelson United States	17	450 0.8×	392 0.9×	408 1.0×	121 0.3×	223 1.2×	42	1.8k
Syed Mohammad Ali Kazmi United States	16	475 0.9×	206 0.4×	262 0.6×	221 0.5×	255 1.3×	79	1.3k
Chris Holcombe United Kingdom	20	526 1.0×	829 1.8×	144 0.3×	325 0.8×	488 2.6×	81	1.8k
Yize Mao China	16	537 1.0×	234 0.5×	193 0.5×	123 0.3×	113 0.6×	40	874
Tom Ehlen Canada	11	448 0.8×	1.2k 2.5×	176 0.4×	186 0.5×	131 0.7×	15	2.3k
Zarnie Lwin Australia	20	533 1.0×	138 0.3×	193 0.5×	268 0.7×	164 0.9×	99	1.3k
Elisabeth Pras Netherlands	24	514 0.9×	275 0.6×	197 0.5×	417 1.0×	133 0.7×	35	1.6k
Ernest I. Kohorn United States	36	488 0.9×	653 1.4×	271 0.6×	210 0.5×	93 0.5×	87	3.1k
Michael Moran United Kingdom	13	305 0.6×	190 0.4×	241 0.6×	237 0.6×	155 0.8×	37	882
Janice S. Kwon Canada	30	765 1.4×	400 0.9×	505 1.2×	352 0.9×	683 3.6×	134	4.0k

Countries citing papers authored by Sumati Gupta

Since Specialization

Citations

This map shows the geographic impact of Sumati Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumati Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumati Gupta more than expected).

Fields of papers citing papers by Sumati Gupta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumati Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumati Gupta. The network helps show where Sumati Gupta may publish in the future.

Co-authorship network of co-authors of Sumati Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Sumati Gupta. A scholar is included among the top collaborators of Sumati Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumati Gupta. Sumati Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ratan, Aakrosh, Michelle L. Churchman, Laura Graham, et al.. (2025). Clinical and Genomic Features of Androgen Indifferent Prostate Cancer. International Journal of Molecular Sciences. 26(2). 679–679. 1 indexed citations

Maughan, Benjamin L., Christopher Dechet, Julia Beck, et al.. (2025). Nivolumab adjuvant to chemo-radiation in localized muscle-invasive urothelial cancer: primary analysis of a multicenter, single-arm, phase II, investigator-initiated trial (NEXT). Journal for ImmunoTherapy of Cancer. 13(3). e010572–e010572. 1 indexed citations

Coletta, Adriana M., Sarah Taylor, Pamela A. Hansen, et al.. (2024). Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial. BMC Cancer. 24(1). 493–493. 1 indexed citations

Gupta, Sumati, et al.. (2024). Pathology focused review of morphologic subtypes and molecular variants of urothelial carcinoma with an emphasis on clinical/treatment relevance. Urologic Oncology Seminars and Original Investigations. 42(7). 193–202.

Loriot, Yohann, Arash Rezazadeh Kalebasty, Aude Fléchon, et al.. (2024). A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancer. Future Oncology. 20(23). 1621–1631. 1 indexed citations

Gupta, Sumati, Pradeep Khanna, Eddy Saad, et al.. (2024). 55 (PB043): Activity of CDK4/6 inhibitors in translocation renal cell carcinoma. European Journal of Cancer. 211. 114582–114582.

Jain, Rohit, Umang Swami, Mehmet Asım Bilen, et al.. (2024). Cabozantinib plus pembrolizumab as first-line therapy for cisplatin-ineligible advanced urothelial carcinoma (PemCab).. Journal of Clinical Oncology. 42(4_suppl). 539–539. 1 indexed citations

Boucher, Kenneth M., Matthew F. Covington, G Fine, et al.. (2024). CaboLu: A phase 1b study of cabozantinib (cabo) in combination with lutetium (Lu 177) vipivotide tetraxetan (LVT) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 42(4_suppl). TPS251–TPS251.

Li, Haoran, Kamal Kant Sahu, Nishita Tripathi, et al.. (2023). Access to Care and Healthcare Quality Metrics for Patients with Advanced Genitourinary Cancers in Urban versus Rural Areas. Cancers. 15(21). 5171–5171. 1 indexed citations

10.

Wetterskog, Daniel, Francesco Orlando, Anuradha Jayaram, et al.. (2023). 1836P Blood based biomarkers identify metastatic castration-resistant prostate cancer (mCRPC) with the greatest benefit from continuing enzalutamide (ENZ) beyond progression in combination with docetaxel (Doc): A pre-specified biomarker study of the phase IIIb PRESIDE trial. Annals of Oncology. 34. S994–S994. 1 indexed citations

11.

Sahu, Kamal Kant, Nicolas Sayegh, Nishita Tripathi, et al.. (2022). A retrospective study to evaluate the efficacy and safety of SARS-CoV-2 vaccine in patients with advanced genitourinary cancers. Heliyon. 8(9). e10583–e10583. 2 indexed citations

12.

Bleicher, Josh, et al.. (2021). Preoperative Advance Care Planning for Older Adults Undergoing Major Abdominal Surgery. American Journal of Hospice and Palliative Medicine®. 39(4). 406–412. 9 indexed citations

13.

Necchi, Andrea, Petros Grivas, Gennady Bratslavsky, et al.. (2021). 710P Comprehensive genomic profiling (CGP) of small cell neuroendocrine carcinoma of the bladder (NEBC). Annals of Oncology. 32. S718–S718. 1 indexed citations

14.

Agarwal, Neeraj, Roberto Nussenzveig, Andrew W. Hahn, et al.. (2020). Prospective Evaluation of Bone Metabolic Markers as Surrogate Markers of Response to Radium-223 Therapy in Metastatic Castration-resistant Prostate Cancer. Clinical Cancer Research. 26(9). 2104–2110. 16 indexed citations

15.

Madison, Russell W., Sumati Gupta, Yasir Y. Elamin, et al.. (2020). Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertions. British Journal of Urology. 125(5). 739–746. 11 indexed citations

16.

Halwani, Ahmad, Vikas Patil, Zachary Burningham, et al.. (2019). Real-world practice patterns in veterans with metastatic castration-resistant prostate cancer. Urologic Oncology Seminars and Original Investigations. 38(1). 1.e1–1.e10. 19 indexed citations

17.

Gupta, Sumati, Timothy J. Parnell, Andrew Butterfield, et al.. (2018). Histone Deacetylase Inhibition Has Targeted Clinical Benefit in ARID1A -Mutated Advanced Urothelial Carcinoma. Molecular Cancer Therapeutics. 18(1). 185–195. 17 indexed citations

18.

Rudin, Charles M., Hardev Pandha, Sumati Gupta, et al.. (2018). Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients. Annals of Oncology. 29. viii732–viii732. 15 indexed citations

19.

Agarwal, Neeraj, Jordan P. McPherson, Sumati Gupta, et al.. (2015). A phase I clinical trial of the effect of belinostat on the pharmacokinetics and pharmacodynamics of warfarin. Cancer Chemotherapy and Pharmacology. 77(2). 299–308. 10 indexed citations

20.

Hamad, Abdullah, et al.. (2002). LACK OF EFFECT OF LONG-TERM USE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS BY HEMODIALYSIS PATIENTS ON THIRST AND FLUID WEIGHT GAIN. Renal Failure. 24(4). 461–466. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact